Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 669
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01022424 | A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002] | ||
| NCT03179787 | Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism | ||
| NCT00428948 | Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) | ||
| NCT02827513 | A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects | ||
| NCT01002950 | Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy | ||
| NCT00972426 | A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients | ||
| NCT03772041 | Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure | ||
| NCT00201994 | "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia | ||
| NCT02360319 | Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics | ||
| NCT03734302 | The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects | ||
| NCT02964273 | Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease) | ||
| NCT04107051 | Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence | ||
| NCT01418339 | Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder | ||
| NCT02251275 | Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease | ||
| NCT01001702 | Oral Aripiprazole Open-Label Rollover Study | ||
| NCT03541447 | Tolvaptan-Octreotide LAR Combination in ADPKD | ||
| NCT02013609 | Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment | ||
| NCT01026584 | Efficacy and Safety of Aripiprazole in First Episode Psychosis | ||
| NCT01782833 | Pletaal SR Post Marketing Observational Study | ||
| NCT05326347 | A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia | ||
| NCT02435836 | A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia | ||
| NCT02538016 | TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study | ||
| NCT01684202 | A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) | ||
| NCT00606177 | A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode | ||
| NCT05326230 | A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO) | ||
| NCT00234104 | A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure) | ||
| NCT02442765 | Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type | ||
| NCT00845988 | Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders | ||
| NCT07166887 | Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male | ||
| NCT05428033 | A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD) | ||
| NCT00277212 | A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode | ||
| NCT01856634 | Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis | ||
| NCT02697045 | Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch | ||
| NCT01360866 | Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) | ||
| NCT01031667 | Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study) | ||
| NCT05687071 | A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia | ||
| NCT06795399 | A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure | ||
| NCT01052077 | Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder | ||
| NCT06931080 | Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients | ||
| NCT02250170 | Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor | ||
| NCT00162942 | Study for the Treatment of Crohn's Disease With Adacolumn | ||
| NCT00130039 | Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II | ||
| NCT03911401 | Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis | ||
| NCT01876381 | A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration | ||
| NCT01447576 | Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder | ||
| NCT06575426 | A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus | ||
| NCT02364947 | A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial) | ||
| NCT02472652 | Aripiprazole, Abilify Maintena Collaborative Clinical Protocol | ||
| NCT00325689 | Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. | ||
| NCT01413178 | A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma |
